A Virtual Heart Failure Optimization Program for Guideline Directed Medical Therapy and Cardiac Rehabilitation - Trial NCT05689086
Access comprehensive clinical trial information for NCT05689086 through Pure Global AI's free database. This phase not specified trial is sponsored by Cambridge Cardiac Care Centre and is currently Recruiting. The study focuses on Heart Failure With Reduced Ejection Fraction. Target enrollment is 400 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Virtual Heart Failure Optimization Program
Observational
other
Sponsor & Location
Cambridge Cardiac Care Centre
Timeline & Enrollment
N/A
Jan 01, 2020
Dec 31, 2023
Primary Outcome
Change from baseline Doses of GDMT,Change from baseline Left Ventricular Ejection Fraction
Summary
The goal of this study is to test the impact of a virtual heart failure optimization program
 on uptake of guideline directed medical therapy, participation in cardiac rehabilitation &
 impact on echocardiographic parameters.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05689086
Non-Device Trial